Heterogeneous expression of serine protease inhibitor maspin in ovarian cancer

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2739-2744

  Bauerschlag, D O ^a   Habermann, M ^b   Weimer, J ^b   Meinhold Heerlein, I ^a   Hilpert, F ^b   Weigel, M ^b   Bauer, M ^b   Mundhenke, C ^b   Jonat, W ^b   Maass, N ^a   Schem, Christian ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Maspin expression; Ovarian cancer; Survival

Indexed keywords

DOCETAXEL; MASPIN; MONOCLONAL ANTIBODY; PACLITAXEL;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RESISTANCE; CANCER STAGING; CELLULAR DISTRIBUTION; CLINICAL EVALUATION; CORRELATION ANALYSIS; ENZYME LOCALIZATION; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; TREATMENT RESPONSE; TUMOR VOLUME;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; SERINE PROTEASES; SERINE PROTEINASE INHIBITORS; SERPINS;

EID: 77955902056     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Omura GA, Brady MF, Homesley HD, Yordan E, Major FJ, Buchsbaum HJ and Park RC: Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol 9: 1138-1150, 1991.
2. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL and Montz FJ: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20: 1248-1259, 2002.
3. Lele SM, Graves K and Gatalica Z: Immunohistochemical detection of maspin is a useful adjunct in distinguishing radial sclerosing lesion from tubular carcinoma of the breast. Appl Immunohistochem Mol Morphol. 8(1): 32-36, 2000. (Pubitemid 30152351)
4. Xia W, Lau YK, Hu MC, Li L, Johnston DA, Sheng S, El-Naggar A and Hung MC: High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 19(20): 2398-2403, 2000. (Pubitemid 30323472)
5. Pierson CR, McGowen R, Grignon D, Sakr W, Dey J and Sheng S: Maspin is up-regulated in premalignant prostate epithelia. Prostate 53(4): 255-262, 2002. (Pubitemid 35398496)
6. Machtens S, Serth J, Bokemeyer C, Bathke W, Minssen A, Kollmannsberger C, Hartmann J, Knüchel R, Kondo M, Jonas U and Kuczyk M: Expression of the p53 and maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer 95(5): 337-342, 2001.
7. Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E and Srivastava S: p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 275(9): 6051-6054, 2000. (Pubitemid 30129884)
8. Zhang M, Magit D and Sager R: Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor. Proc Natl Acad Sci USA 94(11): 5673-5678, 1997. (Pubitemid 27241828)
9. Remmele W and Stegner HE: Vorschlag zur einheitlichen Definition eines Immunreaktiven Score (IRS) für den immunhistochemischen Östrogenrezeptor-Nachweis im Mammakarzinomgewebe. Der Pathologe 8: 138-140, 1987
10. Münstedt K and Stephen J: Steroid hormone receptors and long-term survival in invasive ovarian cancer. Cancer 15 89(8): 1783-1791, 2000
11. Bräutigam K, Bauerschlag DO, Weigel MT, Biernath-Wüpping J, Bauknecht T, Arnold N, Maass N and Meinhold-Heerlein I: Combination of enzastaurin und pemetrexed inhibits cell growth and induces apoptosis of chemoresistant ovarian cancer cells regulating extracellular signal-regulated kinase 1/2 phosphorylation. Translational Oncol 2(3): 164-173, 2009.
12. Lekanne Deprez RH, Fijnvandraat AC, Ruijter JM and Moorman AFM: Sensitivity and accuracy of quantitative real-time polymerase chain reaction using SYBR green I depends on cDNA synthesis conditions. Anal Biochem 307: 63-69, 2002.
13. Schedel J, Distler O, Woenckhaus M, Gay RE, Simmen B, Michel BA, Müller-Ladner U and Gay S: Discrepancy between mRNA and protein expression of tumor suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis. Ann Rheum Dis 63: 1205-1211, 2004. (Pubitemid 39273494)
14. Fitzgerald M, Oshiro M, Holtan N, Krager K, Cullen JJ, Futscher BW and Domann FE: Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control. Neoplasia Vol. 5, 5: 427-436, 2003 (Pubitemid 37475651)
15. Maass N, Hojo T, Ueding M, Lüttges J, Klöppel G, Jonat W and Nagasaki K: Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clini Cancer Res 7: 812-817, 2001. (Pubitemid 32708715)
16. Sood AK, Fletcher Ms, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA and Hendrix MJ: The paradoxical expression of maspin in ovarian carcinoma. Clini Cancer Res 8: 2924-2932, 2002. (Pubitemid 35025740)
17. Abd El-Wahed MM: Expression and subcellular localization of maspin in human ovarian epithelial neoplasms: correlation with clonicopathologic features. J Egypt Natl Canc Inst 17(3): 173-178, 2005.
18. Secord A and Lee P: Maspin expression in epithelial ovarian cancer and sociations with poor prognosis: A gynecolgic oncology group study. Gynecol Oncol 101: 390-397, 2006 (Pubitemid 43744562)
19. Tsuji T, Togami S, Douchi T and Umekita Y: Difference in subcellular localization of maspin expression in ovarian mucinous borderline tumor. Histopathology 55(1): 130-132, 2009.
20. Klasa-Mazurkiewicz D, Narkiewicz J, Milczek T, Lipińska B and Emerich J: Maspin overexpression correlates with positive response to primary chemotherapy in ovarian cancer patients. Gynecol Oncol 113(1): 91-98, 2009.
21. Bolat F, Gumurdulu D, Erkanli S, Kayaselcuk F, Zeren H, Ali Vardar M and Kuscu E: Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C and D in human ovarian carcinoma. Pathol Res Pract 204(6): 379-387, 2008.
22. Rose SL, Fitzgerald MP, White NO, Hitchler MJ, Futscher BW, De Geest K and Domann FE: Epigenetic regulation of maspin expression in human ovarian carcinoma cells. Gynecol Oncol 102: 319-324, 2006. (Pubitemid 44056261)
23. Maass N, Reffner M, Fösel F, Pawaresch R, Jonat W, Nagasaki K and Rudolph P: Decline in the expression of the serine proteinase inhibitor maspin is associated with tumor progression in ductal carcinomas of the breast. J Pathol 195(3): 321-326, 2001.
24. Maass N, Hojo T, Rösel F, Ikeda T, Jonat W and Nagasaki K: Down-regulation of the tumor suppressor gene maspin in breast carcinoma is associated with higher risk of distant metastasis. Clini Biochem 34: 303-307, 2001. (Pubitemid 32607573)
25. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E and Sager R: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263(5146): 526-529, 1994. (Pubitemid 24082753)